These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2022303)

  • 1. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance.
    Fasching P; Ratheiser K; Waldhäusl W; Rohac M; Osterrode W; Nowotny P; Vierhapper H
    Diabetes; 1991 May; 40(5):583-9. PubMed ID: 2022303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
    Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
    Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?
    Giacco R; Cuomo V; Vessby B; Uusitupa M; Hermansen K; Meyer BJ; Riccardi G; Rivellese AA;
    Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):572-80. PubMed ID: 17127043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dietary fish oil supplementation on exercising horses.
    O'Connor CI; Lawrence LM; Lawrence AC; Janicki KM; Warren LK; Hayes S
    J Anim Sci; 2004 Oct; 82(10):2978-84. PubMed ID: 15484950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats.
    Chicco A; D'Alessandro ME; Karabatas L; Gutman R; Lombardo YB
    Ann Nutr Metab; 1996; 40(2):61-70. PubMed ID: 8773730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
    Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
    Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fish oil does not alter glucose tolerance in conscious rats.
    Behme MT; Dupre J; Holub BJ; Philbrick DJ
    J Nutr; 1993 Dec; 123(12):2085-9. PubMed ID: 8263601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish oil attenuates adrenergic overactivity without altering glucose metabolism during an oral glucose load in haemodialysis patients.
    Delarue J; Guillodo MP; Guillerm S; Elbaz A; Marty Y; Clèdes J
    Br J Nutr; 2008 May; 99(5):1041-7. PubMed ID: 17977474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of effects of dietary fish oil supplementation on serum eicosapentaenoic acid and docosahexaenoic acid concentrations in dogs.
    Hansen RA; Ogilvie GK; Davenport DJ; Gross KL; Walton JA; Richardson KL; Mallinckrodt CH; Hand MS; Fettman MJ
    Am J Vet Res; 1998 Jul; 59(7):864-8. PubMed ID: 9659553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fish oil supplements in NIDDM subjects. Controlled study.
    Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
    Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial.
    Clark LF; Thivierge MC; Kidd CA; McGeoch SC; Abraham P; Pearson DW; Horgan GW; Holtrop G; Thies F; Lobley GE
    Br J Nutr; 2016 Jan; 115(1):75-86. PubMed ID: 26537735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.
    Glauber H; Wallace P; Griver K; Brechtel G
    Ann Intern Med; 1988 May; 108(5):663-8. PubMed ID: 3282462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.
    Fasching P; Rohac M; Liener K; Schneider B; Nowotny P; Waldhäusl W
    Horm Metab Res; 1996 May; 28(5):230-6. PubMed ID: 8738112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of arachidonic acid in the regulation of the inflammatory response in TNF-alpha-treated rats.
    Ling PR; Boyce P; Bistrian BR
    JPEN J Parenter Enteral Nutr; 1998; 22(5):268-75. PubMed ID: 9739028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
    PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.